XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,121,980 | +218.0% | 91,500 | +258.8% | 1.05% | +251.8% |
| Q2 2023 | $981,750 | +7.6% | 25,500 | 0.0% | 0.30% | +17.3% |
| Q1 2023 | $912,390 | -9.1% | 25,500 | 0.0% | 0.26% | -17.7% |
| Q4 2022 | $1,003,425 | +9.3% | 25,500 | 0.0% | 0.31% | +5.4% |
| Q3 2022 | $918,000 | -96.4% | 25,500 | +3194.6% | 0.29% | +10.5% |
| Q2 2022 | $25,500,000 | +697.4% | 774 | -97.0% | 0.27% | -63.1% |
| Q1 2022 | $3,198,000 | +301.3% | 25,500 | 0.0% | 0.72% | +305.1% |
| Q4 2021 | $797,000 | +105.4% | 25,500 | 0.0% | 0.18% | +89.4% |
| Q3 2021 | $388,000 | -18.1% | 25,500 | 0.0% | 0.09% | -24.8% |
| Q2 2021 | $474,000 | – | 25,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |